Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246): Correction

K Fizazi; N Shore; TL Tammela; A Ulys; E Vjaters; S Polyakov; M Jievaltas; M Luz; B Alekseev; I Kuss; C Kappeler; A Snapir; T Sarapohja; MR Smith

doi:10.1056/NEJMx220007

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246): Correction

K Fizazi, N Shore, TL Tammela, A Ulys, E Vjaters, S Polyakov, M Jievaltas, M Luz, B Alekseev, I Kuss, C Kappeler, A Snapir, T Sarapohja, MR Smith

Research output: Contribution to journal › Erratum › peer-review

Original language	English
Pages (from-to)	860-860
Number of pages	1
Journal	New England Journal of Medicine
Volume	387
Issue number	9
DOIs	https://doi.org/10.1056/NEJMx220007
Publication status	Published - 1 Sept 2022
Externally published	Yes

Field of Science*

3.2 Clinical medicine

Publication Type*

6. Other publications

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMx220007

https://www.nejm.org/doi/pdf/10.1056/NEJMx220007?articleTools=true

Cite this

Fizazi, K., Shore, N., Tammela, TL., Ulys, A., Vjaters, E., Polyakov, S., Jievaltas, M., Luz, M., Alekseev, B., Kuss, I., Kappeler, C., Snapir, A., Sarapohja, T., & Smith, MR. (2022). Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246): Correction. New England Journal of Medicine, 387(9), 860-860. https://doi.org/10.1056/NEJMx220007

@article{6a74a1c93f5648459b90e1f79fdb14df,

title = "Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246): Correction",

author = "K Fizazi and N Shore and TL Tammela and A Ulys and E Vjaters and S Polyakov and M Jievaltas and M Luz and B Alekseev and I Kuss and C Kappeler and A Snapir and T Sarapohja and MR Smith",

year = "2022",

month = sep,

day = "1",

doi = "10.1056/NEJMx220007",

language = "English",

volume = "387",

pages = "860--860",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "9",

}

Fizazi, K, Shore, N, Tammela, TL, Ulys, A, Vjaters, E, Polyakov, S, Jievaltas, M, Luz, M, Alekseev, B, Kuss, I, Kappeler, C, Snapir, A, Sarapohja, T & Smith, MR 2022, 'Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246): Correction', New England Journal of Medicine, vol. 387, no. 9, pp. 860-860. https://doi.org/10.1056/NEJMx220007

TY - JOUR

T1 - Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246)

T2 - Correction

AU - Fizazi, K

AU - Shore, N

AU - Tammela, TL

AU - Ulys, A

AU - Vjaters, E

AU - Polyakov, S

AU - Jievaltas, M

AU - Luz, M

AU - Alekseev, B

AU - Kuss, I

AU - Kappeler, C

AU - Snapir, A

AU - Sarapohja, T

AU - Smith, MR

PY - 2022/9/1

Y1 - 2022/9/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:000849132700022&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1056/NEJMx220007

DO - 10.1056/NEJMx220007

M3 - Erratum

SN - 0028-4793

VL - 387

SP - 860

EP - 860

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 9

ER -

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246): Correction

Field of Science*

Publication Type*

UN SDGs

Access to Document

Other files and links

Darolutamide in nonmetastatic, castration-resistant prostate cancer

Cite this